In primary BC cells and BC CML cell lines, ARG2 expression was more heterogeneous (Fig 1A, 1B and 1E), possibly due to the genetic diversity of BC disease [39]. This evidence concerns the gene ARG2 and chronic myelogenous leukemia, BCR-ABL1 positive.